Substituted Pyrrolidine Amides I
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,626,106 | Substituted Pyrrolidine Amides I In force · High confidence UsedRemaining | Gruenenthal GmbH | In force | High confidence | ||
| US 12,344,605 | Substituted Pyrrolidine Amides II In force · High confidence | Gruenenthal GmbH | In force | High confidence | ||
| US 8,618,129 | Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators Lapsed Dec 31, 2017 on the fee record High confidence | Gruenenthal GmbH | Lapsed Dec 31, 2017 on the fee record | High confidence | ||
| US 9,073,862 | Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators Lapsed Jul 7, 2019 on the fee record High confidence | Gruenenthal GmbH | Lapsed Jul 7, 2019 on the fee record | High confidence | ||
| US 9,078,899 | Pyrazolyl-Based Carboxamides II Lapsed Jul 14, 2019 on the fee record Medium confidence | Gruenenthal GmbH | Lapsed Jul 14, 2019 on the fee record | Medium confidence | ||
| US 9,206,136 | Pyrazolyl-Based Carboxamides I Lapsed Dec 8, 2019 on the fee record Medium confidence | Gruenenthal GmbH | Lapsed Dec 8, 2019 on the fee record | Medium confidence | ||
| US 8,178,684 | Substituted Nicotinamides as KCNQ2/3 Modulators Lapsed May 15, 2020 on the fee record Medium confidence | Gruenenthal GmbH | Lapsed May 15, 2020 on the fee record | Medium confidence | ||
| US 8,445,512 | Substituted quinoline-3-carboxamides as KCNQ2/3 modulators Lapsed May 21, 2021 on the fee record High confidence | Gruenenthal GmbH | Lapsed May 21, 2021 on the fee record | High confidence | ||
| US 8,470,852 | Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators Lapsed Jun 25, 2021 on the fee record High confidence | Gruenenthal GmbH | Lapsed Jun 25, 2021 on the fee record | High confidence | ||
| US 8,552,200 | Substituted 6-Amino-NICOTINAMIDES as KCNQ2/3 Modulators Lapsed Oct 8, 2021 on the fee record High confidence | Gruenenthal GmbH | Lapsed Oct 8, 2021 on the fee record | High confidence | ||
| 12 more records in this group · Pro | ||||||
10 of 22 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 22, including 16 expired.
2 of these are in force and held by Gruenenthal GmbH.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.